iRhythm Holdings, Inc. Net Change in Cash
iRhythm Holdings, Inc. (IRTC) reported Net Change in Cash of $10.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-06
- iRhythm Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $4.13M.
- iRhythm Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$44.32M, a 109.00% decline year-over-year.
- iRhythm Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $492.61M.
- iRhythm Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$26.03M.
- iRhythm Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$183.59M, a 146.86% decline from fiscal 2024.
- iRhythm Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $391.78M.
- iRhythm Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$42.66M.
- iRhythm Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$48.73M, a 225.16% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10.67M 10-Q · filed 2026-08-06 | |||||
| 2026-03-31 | $4.13M 10-Q · filed 2026-04-30 | |||||
| 2025-12-31 | -$183.59M 10-K · filed 2026-02-19 | |||||
| 2025-09-30 | -$163.99M 10-Q · filed 2025-10-30 | |||||
| 2025-06-30 | -$110.49M 10-Q · filed 2026-08-06 | |||||
| 2025-03-31 | -$44.32M 10-Q · filed 2026-04-30 | |||||
| 2024-12-31 | $391.78M 10-K · filed 2026-02-19 | |||||
| 2024-09-30 | $491.72M 10-Q · filed 2025-10-30 | |||||
| 2024-06-30 | $522.74M 10-Q · filed 2025-07-31 | |||||
| 2024-03-31 | $492.61M 10-Q · filed 2025-05-01 | |||||
| 2023-12-31 | -$42.66M 10-K · filed 2026-02-19 | |||||
| 2023-09-30 | -$31.35M 10-Q · filed 2024-10-30 | |||||
| 2023-06-30 | -$17.25M 10-Q · filed 2024-08-01 | |||||
| 2023-03-31 | -$26.03M 10-Q · filed 2024-05-02 | |||||
| 2022-12-31 | -$48.73M 10-K · filed 2025-02-20 | |||||
| 2022-09-30 | -$56.34M 10-Q · filed 2023-11-02 | |||||
| 2022-06-30 | -$26.31M 10-Q · filed 2023-08-04 | |||||
| 2022-03-31 | -$32.78M 10-Q · filed 2023-05-04 | |||||
| 2021-12-31 | $38.93M 10-K · filed 2024-02-22 | |||||
| 2021-09-30 | $78.74M 10-Q · filed 2022-11-04 | |||||
| 2021-06-30 | $50.24M 10-Q · filed 2022-08-05 | |||||
| 2021-03-31 | $48.75M 10-Q · filed 2022-05-06 | |||||
| 2020-12-31 | $68.17M 10-K · filed 2023-02-23 | |||||
| 2020-09-30 | $74.87M 10-Q · filed 2021-11-05 | |||||
| 2020-06-30 | $61.27M 10-Q · filed 2021-08-09 | |||||
| 2020-03-31 | $36.05M 10-Q · filed 2021-05-10 | |||||
| 2019-12-31 | $439.00K 10-K · filed 2022-02-28 | |||||
| 2019-09-30 | $14.61M 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | -$4.04M 10-Q · filed 2020-08-07 | -$3.87M 10-Q · filed 2019-08-06 | ||||
| 2019-03-31 | $8.08M 10-Q · filed 2020-05-08 | $8.21M 10-Q · filed 2019-05-10 | ||||
| 2018-12-31 | $11.35M 10-K · filed 2021-02-26 | |||||
| 2018-09-30 | $8.67M 10-Q · filed 2019-12-23 | |||||
| 2018-06-30 | $10.57M 10-Q · filed 2019-08-06 | |||||
| 2018-03-31 | $7.80M 10-Q · filed 2019-05-10 | |||||
| 2017-12-31 | -$43.06M 10-K · filed 2020-03-02 | |||||
| 2017-09-30 | -$31.30M 10-Q · filed 2018-10-30 | |||||
| 2017-06-30 | -$35.39M 10-Q · filed 2018-08-03 | |||||
| 2016-12-31 | $26.43M 10-K · filed 2019-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |